Sridhar Narla

598 total citations
18 papers, 430 citations indexed

About

Sridhar Narla is a scholar working on Molecular Biology, Surgery and Urology. According to data from OpenAlex, Sridhar Narla has authored 18 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Surgery and 5 papers in Urology. Recurrent topics in Sridhar Narla's work include Fibroblast Growth Factor Research (7 papers), Urological Disorders and Treatments (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Sridhar Narla is often cited by papers focused on Fibroblast Growth Factor Research (7 papers), Urological Disorders and Treatments (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Sridhar Narla collaborates with scholars based in United States, Poland and Germany. Sridhar Narla's co-authors include Michal K. Stachowiak, Ewa K. Stachowiak, Courtney A. Benson, Pinaki Sarder, Kristen Brennand, Barbara Birkaya, Merouane Bencherif, Darcy A. Freedman, Alexander J. Dimitri and Christopher Terranova and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Biochemical Pharmacology.

In The Last Decade

Sridhar Narla

18 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sridhar Narla United States 11 335 81 64 52 44 18 430
Thomas F. Allison United Kingdom 7 345 1.0× 90 1.1× 52 0.8× 71 1.4× 63 1.4× 10 508
Sean McGrath United States 5 572 1.7× 149 1.8× 80 1.3× 40 0.8× 64 1.5× 6 722
Tameji Eames United Kingdom 4 271 0.8× 196 2.4× 50 0.8× 29 0.6× 74 1.7× 5 407
Alice Braga United Kingdom 8 190 0.6× 75 0.9× 54 0.8× 15 0.3× 18 0.4× 14 461
Mats Nilbratt Sweden 7 257 0.8× 128 1.6× 126 2.0× 28 0.5× 48 1.1× 7 369
Kazuo Hashido Japan 11 509 1.5× 69 0.9× 80 1.3× 61 1.2× 8 0.2× 16 675
Ábel Vértesy Austria 9 310 0.9× 43 0.5× 50 0.8× 80 1.5× 43 1.0× 12 437
Márcia Urban-Maldonado United States 13 477 1.4× 122 1.5× 22 0.3× 55 1.1× 7 0.2× 17 649
Cosima Fonte France 6 153 0.5× 117 1.4× 93 1.5× 45 0.9× 18 0.4× 8 323
Shigeki Omachi Japan 7 373 1.1× 222 2.7× 160 2.5× 24 0.5× 21 0.5× 9 535

Countries citing papers authored by Sridhar Narla

Since Specialization
Citations

This map shows the geographic impact of Sridhar Narla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridhar Narla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridhar Narla more than expected).

Fields of papers citing papers by Sridhar Narla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sridhar Narla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridhar Narla. The network helps show where Sridhar Narla may publish in the future.

Co-authorship network of co-authors of Sridhar Narla

This figure shows the co-authorship network connecting the top 25 collaborators of Sridhar Narla. A scholar is included among the top collaborators of Sridhar Narla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sridhar Narla. Sridhar Narla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Narla, Sridhar, et al.. (2022). AKT Signaling Downstream of KGF Is Necessary and Sufficient for Blocking Cyclophosphamide Bladder Injury. American Journal Of Pathology. 192(4). 604–612. 7 indexed citations
2.
Narla, Sridhar, Lori Rice, David A. Ostrov, et al.. (2022). FGF7 peptide (FGF7p) mimetic mitigates bladder urothelial injury from cyclophosphamide. Physiological Reports. 10(7). e15241–e15241. 3 indexed citations
3.
Narla, Sridhar, et al.. (2022). Durability of and role of AKT in FGF7p urothelial protection against cyclophosphamide. Physiological Reports. 10(12). e15358–e15358. 1 indexed citations
4.
Narla, Sridhar, Daniel Bushnell, Mehdi Nouraie, et al.. (2022). Role of ERK signaling in bladder urothelium in response to cyclophosphamide injury. Physiological Reports. 10(14). 2 indexed citations
5.
Jackson, Ashley R., Sridhar Narla, Carlton M. Bates, & Brian Becknell. (2021). Urothelial progenitors in development and repair. Pediatric Nephrology. 37(8). 1721–1731. 9 indexed citations
6.
Stachowiak, Michal K., et al.. (2020). Neurogenesis and Oligodendrogenesis in a Mouse Model of Blast-Induced Traumatic Brain Injury. 1–14. 3 indexed citations
7.
Narla, Sridhar, Daniel Bushnell, Caitlin Schaefer, et al.. (2020). Loss of Fibroblast Growth Factor Receptor 2 (FGFR2) Leads to Defective Bladder Urothelial Regeneration after Cyclophosphamide Injury. American Journal Of Pathology. 191(4). 631–651. 14 indexed citations
8.
Narla, Sridhar, Daniel Bushnell, Caitlin Schaefer, Mehdi Nouraie, & Carlton M. Bates. (2019). Keratinocyte Growth Factor Reduces Injury and Leads to Early Recovery from Cyclophosphamide Bladder Injury. American Journal Of Pathology. 190(1). 108–124. 16 indexed citations
9.
Narla, Sridhar, et al.. (2018). Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia. Results and problems in cell differentiation. 66. 137–162. 6 indexed citations
10.
Narla, Sridhar, Courtney A. Benson, Pinaki Sarder, et al.. (2017). Common developmental genome deprogramming in schizophrenia — Role of Integrative Nuclear FGFR1 Signaling (INFS). Schizophrenia Research. 185. 17–32. 46 indexed citations
11.
Stachowiak, Ewa K., Courtney A. Benson, Sridhar Narla, et al.. (2017). Cerebral organoids reveal early cortical maldevelopment in schizophrenia—computational anatomy and genomics, role of FGFR1. Translational Psychiatry. 7(11). 6–6. 126 indexed citations
12.
Terranova, Christopher, Sridhar Narla, Jonathan Bard, et al.. (2015). Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1). PLoS ONE. 10(4). e0123380–e0123380. 35 indexed citations
13.
Bencherif, Merouane, et al.. (2014). Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System. CNS & Neurological Disorders - Drug Targets. 13(5). 836–845. 24 indexed citations
14.
Stachowiak, Michal K., Barbara Birkaya, John M. Aletta, et al.. (2014). “Nuclear FGF Receptor‐1 and CREB Binding Protein: An Integrative Signaling Module”. Journal of Cellular Physiology. 230(5). 989–1002. 24 indexed citations
15.
Narla, Sridhar, Ilona Klejbor, Barbara Birkaya, et al.. (2013). α7 Nicotinic receptor agonist reactivates neurogenesis in adult brain. Biochemical Pharmacology. 86(8). 1099–1104. 29 indexed citations
16.
Narla, Sridhar, Ilona Klejbor, Barbara Birkaya, et al.. (2013). Activation of Developmental Nuclear Fibroblast Growth Factor Receptor 1 Signaling and Neurogenesis in Adult Brain by α7 Nicotinic Receptor Agonist. Stem Cells Translational Medicine. 2(10). 776–788. 21 indexed citations
17.
Lee, Yu‐Wei, Christopher Terranova, Barbara Birkaya, et al.. (2012). A novel nuclear FGF Receptor‐1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. Journal of Cellular Biochemistry. 113(9). 2920–2936. 27 indexed citations
18.
Stachowiak, Michal K., Aaron Kucinski, Sridhar Narla, et al.. (2012). Schizophrenia: A neurodevelopmental disorder — Integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophrenia Research. 143(2-3). 367–376. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas F. Allison Breakdown of academic impact, for papers by Sean McGrath Breakdown of academic impact, for papers by Tameji Eames Breakdown of academic impact, for papers by Alice Braga Breakdown of academic impact, for papers by Mats Nilbratt Breakdown of academic impact, for papers by Kazuo Hashido Breakdown of academic impact, for papers by Ábel Vértesy Breakdown of academic impact, for papers by Márcia Urban-Maldonado Breakdown of academic impact, for papers by Cosima Fonte Breakdown of academic impact, for papers by Shigeki Omachi
Rankless by CCL
2026